# Intravitreal Carboplatin for the Treatment of Participants With Recurrent or Refractory Intraocular Retinoblastoma

> **NCT02792036** · PHASE1 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 8 (actual)

## Conditions studied

- Retinoblastoma

## Interventions

- **DRUG:** Carboplatin
- **DRUG:** Maxitrol®
- **PROCEDURE:** Focal Therapy
- **PROCEDURE:** Plaque Radiotherapy

## Key facts

- **NCT ID:** NCT02792036
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-01
- **Primary completion:** 2019-10-04
- **Final completion:** 2019-10-04
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2020-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02792036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02792036, "Intravitreal Carboplatin for the Treatment of Participants With Recurrent or Refractory Intraocular Retinoblastoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02792036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*